Comparisons of anti-human immunodeficiency virus activities, cellular transport, and plasma and intracellular pharmacokinetics of 3'-fluoro-3'-deoxythymidine and 3'-azido-3'-deoxythymidine.

Míreanna Comhchosúla

• Synergistic inhibition of human immunodeficiency virus type 1 replication in vitro by two-drug and three-drug combinations of 3'-azido-3'-deoxythymidine, phosphonoformate, and 2',3'-dideoxythymidine.
  le: Kong, X B, et al.
  Foilsithe: (1991)
• Mutants of feline immunodeficiency virus resistant to 3'-azido-3'-deoxythymidine.
  le: Remington, K M, et al.
  Foilsithe: (1991)
• Sanctuary growth of human immunodeficiency virus in the presence of 3'-azido-3'-deoxythymidine.
  le: Medina, D J, et al.
  Foilsithe: (1995)
• Human immunodeficiency virus inhibition is prolonged by 3'-azido-3'-deoxythymidine alternating with 2',3'-dideoxycytidine compared with 3'-azido-3'-deoxythymidine alone.
  le: Spector, S A, et al.
  Foilsithe: (1989)
• Inhibition of human immunodeficiency virus in vitro by combinations of 3'-azido-3'-deoxythymidine and foscarnet.
  le: Koshida, R, et al.
  Foilsithe: (1989)